# Biomatter Closes Oversubscribed $18 million Series A to Fund Vilnius Facility and US Expansion

> Biomatter closed an oversubscribed $18 million Series A led by Astanor to fund a 2,000 m² Vilnius facility opening in 2027 and expand its US commercial team.

- Published: 2026-11-12T05:41:41+00:00
- Section: Funding
- Author: News Desk
- URL: https://newsforagent.com/news/2026-11-12/biomatter-series-a-astanor
- Source: [TradingView](https://www.tradingview.com/news/tradingview:f5b74144fc754:0-biomatter-raises-18m-series-a-to-expand-operations/)

## Key takeaways

- Biomatter closed an oversubscribed $18 million Series A led by Astanor.
- Proceeds will fund a 2,000 m² Vilnius facility opening in 2027, US expansion and platform investment.
- Biomatter has delivered more than 50 enzymes to 25 or more customers, about half of them based in the US.

Biomatter closed an oversubscribed $18 million Series A led by Astanor, the company said in a release distributed by EQS. [TradingView](https://www.tradingview.com/news/tradingview:f5b74144fc754:0-biomatter-raises-18m-series-a-to-expand-operations/) published the announcement on November 12, 2026. The proceeds will fund a 2,000 m² facility in Vilnius opening in 2027, commercial-team and US expansion, and continued investment in the company's platform.

## Biomatter's Vilnius Facility and US Push

[Biomatter](https://akta.pro/company-profiles/0000s5l/biomatter) said the new Vilnius facility is intended to bring design-and-test cycles from weeks to days. The company said the release gives no prior financing comparison or valuation. Biomatter said it has delivered more than 50 enzymes to 25 or more customers, and that roughly half of those customers are based in the US. The release gives no revenue or customer-concentration figures and no quantified growth target for the US expansion.

Astanor Ventures led the round. [Astanor](https://akta.pro/company-profiles/00004i5/astanor-ventures) and Avenue Capital led a USD140m+ investment in ProducePay, a US-based agricultural financing and technology platform operating across Latin America and other markets, LAVCA reported on September 24, 2026. That round marked the first close of The Amazon Reforestation Fund II.

## Biomatter's Earlier Rounds and Partners

Biomatter's [funding records](https://akta.pro/company-data) on akta.pro list three rounds. The company closed a €6.5 million seed round in August 2024 co-led by Inventure VC and UVC Partners to scale generative AI enzyme design for industrial applications. The same records list a January 2021 seed of $608,000 led by Practica Capital and a January 2021 pre-seed of $608,000 led by Practica Capital. Biomatter was founded in 2019 and is headquartered in Vilnius.

| Round | Date | Amount | Lead investor |
|---|---|---|---|
| Pre-seed | January 2021 | $608,000 | Practica Capital |
| Seed | January 2021 | $608,000 | Practica Capital |
| Seed | August 2024 | €6.5 million | Inventure VC and UVC Partners |

The same records list partnerships with Thermo Fisher Scientific, BASF and Neogen, and more than five global partners including Cargill, Thermo Fisher Scientific, BASF, Neogen and Kirin. Biomatter uses its Intelligent Architecture platform to design novel enzymes for industrial biotechnology applications.

## Biomatter's 2027 Facility Timeline

The Vilnius facility is scheduled to open in 2027, according to the company's announcement.

## Companies in this story

- [Biomatter company profile](https://akta.pro/company-profiles/0000s5l/biomatter) · website: http://www.biomatter.com
- [Astanor Ventures company profile](https://akta.pro/company-profiles/00004i5/astanor-ventures) · website: https://www.astanor.com

---
News for Agent · https://newsforagent.com/llms.txt